(195 days)
Not Found
No
The document describes a medical display system and its components (display, graphics board, QA software). There is no mention of AI or ML in the intended use, device description, or any other section. The focus is on displaying and viewing images, not analyzing them with AI/ML algorithms.
No.
The device is a medical display system intended for viewing digital images for review and analysis by medical practitioners, not for treating any medical condition.
No
The device is a display system used for viewing and analyzing digital medical images. It does not perform any diagnostic functions itself but rather presents data for medical practitioners to use in their diagnostic process.
No
The device description explicitly states it consists of three components: a grayscale LCD display (MDNG-5121 CB), a display controller board (BarcoMed Nio), and a software application (NioWatch). This indicates it is a hardware and software system, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for displaying and viewing digital images for review and analysis by medical practitioners. This is a display system for medical imaging, not a device that performs tests on biological samples (in vitro).
- Device Description: The device is described as a display system consisting of a display, a display controller board, and QA software. None of these components are involved in performing in vitro diagnostic tests.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting analytes, or providing diagnostic information based on in vitro testing.
Therefore, the Nio 5MP-21" is a medical imaging display system, not an IVD.
N/A
Intended Use / Indications for Use
"The Nio 5MP-21" is intended to be used in displaying digital images, including digital mammography, for review and analysis by trained medical practitioners. The Nio 5MP-21", containing the display MDNG-5121 CB, the software NioWatch and the graphic board BarcoMed Nio, will be marketed as separate device.
Product codes
90LLZ
Device Description
Nio 5MP-21" is a display system for medical viewing. It consists of 3 components: MDNG-5121 CB is a 21.3" grayscale LCD display. BarcoMed Nio is a fast high-resolution display controller board that plugs into a PACS workstation computer. NioWatch is a softcopy QA software application for local calibration and QA control. The display system can be a single-head system or multi-head system. In the last case it contains multiple displays and display controller boards.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained medical practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
KD62621
510(K) SUMMARY
In accordance with 21 CFR 807.92
1. Date of preparation
September 1, 2006
MAR 1 9 2007
2. Company information
BarcoView 35 President Kennedypark B-8500 Kortrijk, Belgium Tel. +32-(0)56-233-211 Fax +32-(0)56-233-457
3. Contact person
Lieven De Wandel Official correspondent
4. Device information
- Trade name: Nio 5MP-21" .
- Common name: Display system, medical image workstation, and others .
- . Classification name: System, Image Processing
- . Classification number: 21 CFR 892.2050 / Procode 90LLZ
5. Predicate device
- Name: Coronis 5MP .
- . 510(k) number: K042221
- Manufacturer: Barco NV .
6. Device description
Nio 5MP-21" is a display system for medical viewing. It consists of 3 components:
MDNG-5121 CB is a 21.3" grayscale LCD display. BarcoMed Nio is a fast high-resolution display controller board that plugs into a PACS workstation computer. NioWatch is a softcopy QA software application for local calibration and QA control.
The display system can be a single-head system or multi-head system. In the last case it contains multiple displays and display controller boards.
7. Intended use
"The Nio 5MP-21" is intended to be used in displaying digital images, including digital mammography, for review and analysis by trained medical practitioners. The Nio 5MP-21", containing the display MDNG-5121 CB, the software NioWatch and the graphic board
1
BarcoMed Nio, will be marketed as separate device.
8. Summary of technological characteristics
The device consists of three components:
- One 5-megapixel flat panel display (MDNG-5121 CB) .
- One 10-bit display controller (BarcoMed Nio board) .
- . NioWatch software
The flat panel display has a resolution of 2560x2048 pixels. It can be used in landscape and portrait mode.
The BarcoMed Nio display controller board is an ultra-high speed board with an 8-bit in, 10-bit out lookup table, providing 256 simultaneous shades of gray.
The NioWatch software allows to set the display test patterns, calibrate the display and view additional display and display controller information.
Compared to the predicate device, the display of the Nio 5MP-21" system uses the same LCD panel but does not have a built-in front sensor (I-Guard). The accompanying software application has a lower functionality. However, the basic specifications and functions of both systems are the same.
The device does not come into contact with the patient. It does not control any life sustaining devices either.
9. Conclusion:
The Barco Nio 5MP-21" is substantially equivalent to the predicate device, Coronis 5MP. The new and predicate devices are substantially equivalent in the areas of technical characteristics, general function, application and intended use.
Any difference between both devices does not affect safety or efficacy.
The 510(k) Pre-Market Notification for the Barco Nio 5MP-21" contains adequate information and data to enable FDA - CDRH to determine substantial equivalence to the predicate device.
2
510(K) SUMMARY
In accordance with 21 CFR 807.92
1. Date of preparation
September 1, 2006
2. Company information
BarcoView 35 President Kennedypark
B-8500 Kortrijk, Belgium Tel. +32-(0)56-233-211 Fax +32-(0)56-233-457
3. Contact person
Lieven De Wandel Official correspondent
4. Device information
- Trade name: MDNG-5121 CB .
- Common name: Display system, medical image workstation, and others .
- Classification name: System, Image Processing .
- . Classification number: 21 CFR 892.2050 / Procode 90LLZ
5. Predicate device
- Name: MFGD 5421 .
- 510(k) number: K042221 .
- . Manufacturer: Barco NV
6. Device description
MDNG-5121 CB is a 21.3" gravscale LCD display for medical viewing. It is combined with NioWatch, a user-friendly software application that allows to optimize the display for DICOMcompliant viewing.
7. Intended use
"The MDNG-5121 CB is intended to be used in displaying digital images, including digital mammoqraphy, for review and analysis by trained medical practitioners.The MDNG-5121 CB, which is part of the Nio 5MP-21" system, will be marketed separately.
8. Summary of technological characteristics
3
The flat panel display has a resolution of 2560x2048 pixels. It can be used in landscape or portrait mode.
The NioWatch software allows to set the display test patterns, calibrate the display and view additional display and display controller information.
Compared to the predicate device, the MDNG-5121 CB display uses the same LCD panel but does not have a built-in front sensor (I-Guard).
The device does not come into contact with the patient. It does not control any life sustaining devices either.
9. Conclusion:
The Barco MDNG-5121 CB is substantially equivalent to the predicate device, MFGD 5421. The new and predicate devices are substantially equivalent in the areas of technical characteristics, general function, application and intended use.
Any difference between both devices does not affect safety or efficacy.
The 510(k) Pre-Market Notification for the Barco MDNG-5121. CB contains adequate information and data to enable FDA - CDRH to determine substantial equivalence to the predicate device.
4
Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the department's name around the perimeter. In the center of the logo is a stylized image of an eagle or bird-like figure. The image is black and white.
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
Lieven De Wandel Official Correspondent. BarcoView Medical Imaging Systems 35 President Kennedypark B-8500 Kortrijk BELGIUM
MAR 1 9 2007
Re: K062621
Trade/Device Name: Nio 5MP-21 Regulation Number: 21 CFR §892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: December 13, 2006 Received: December 18, 2006
Dear Mr. De Wandel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the individe for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registrations , listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your may publish further and of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/4/Picture/10 description: The image is a black and white circular logo. The logo contains the text "1906-2006" at the top, followed by the letters "FDA" in a bold, blocky font. Below the letters, the word "Centennial" is written in a cursive font. There are three stars below the word "Centennial". The logo is surrounded by a thick black border.
Protecting and Promoting Public Health
5
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html
Sincerely vours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE
510(k) Number (if known): K062621
Device Name: Nio 5MP-21"
Indications for Use:
"The Nio 5MP-21″ is intended to be used in displaying and viewing digital images, including digital mammography, for review and analysis by trained medical practitioners. The Nio 5MP-21", containing the display MDNG-5121 CB, the software NioWatch and the graphic board BarcoMed Nio, will be marketed as separate device.
Prescription Use XX
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use - -
(21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE (CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nancy C. Brogdon
(Division Sion-Off) Division of Reproductive, Abdo and Radiological Devices 510(k) Number